Back
Biomarin Pharmaceutical 10K Form
Buy
64
BMRN
Biomarin Pharmaceutical
Last Price:
64.87
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
2024-02-26 | 10K | BMRN/Biomarin Pharmaceutical Annual |
2023-11-02 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
2023-08-02 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
2023-04-28 | 10Q | BMRN/Biomarin Pharmaceutical Quarterly |
2023-02-27 | 10K | BMRN/Biomarin Pharmaceutical Annual |
Receive BMRN News And Ratings
See the #1 stock for the next 7 days that we like better than BMRN
BMRN Financial Statistics
Sales & Book Value
Annual Sales: | $2.42B |
---|---|
Cash Flow: | $200.31M |
Price / Cash Flow: | 42.48 |
Annual Sales: | $28.41 |
Price / Book: | 2.29 |
Profitability
EPS (TTM): | 1.67000 |
---|---|
Net Income (TTM): | $322.29M |
Gross Margin: | $1.9B |
Return on Equity: | 6.29% |
Return on Assets: | 4.69% |
Biomarin Pharmaceutical Earnings Forecast
Key Biomarin Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 26 years for BMRN is 78.72%.
- The Selling, General & Administrative Expenses for BMRN have been equal to 38.74% of Gross Profit Margin.
- The Research & Development expenses have been 30.87% of Revenue.
- The Interest Expense is 9.99% of Operating Income.
- The Net Earning history of BMRN is 6.93% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Biomarin Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | BMRN |
CUSIP: | 09061G |
Website: | biomarin.com |
Debt
Debt-to-Equity Ratio: | 0.11 |
---|---|
Current Ratio: | 4.27 |
Quick Ratio: | 2.39 |
Price-to-Earnings
Trailing P/E Ratio: | 74.82 |
---|---|
Forward P/E Ratio: | 15.87 |
BMRN Technical Analysis vs Fundamental Analysis
Buy
64
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $65.09. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.